All studies
RecruitingOBSERVATIONAL

MPS (RaDiCo Cohort) (RaDiCo-MPS)

This study, called RaDiCo-MPS, is all about understanding a group of rare genetic conditions known as Mucopolysaccharidoses, or MPS for short. These conditions affect how the body breaks down certain sugars, which can lead to various health problems. Rather than testing new treatments, this is an 'observational' study. This means researchers are collecting detailed health information from people in France who have MPS. They are looking at existing medical records and following patients over time to build a complete picture of how MPS conditions develop and affect people throughout their lives. The main goal is to improve our knowledge of MPS, which can then help doctors and scientists find better ways to diagnose and care for patients in the future.

At a glance

Status
Recruiting
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Enrolment target
1,000
Start
20 Dec 2017
Estimated completion
01 Dec 2026

What is this study about?

Imagine your body as a finely tuned machine, with many different parts working together perfectly. For people with Mucopolysaccharidoses (MPS), some of these parts, specifically the enzymes that break down certain sugar molecules, don't work quite right. This means these sugar molecules can build up in different parts of the body, leading to a range of health issues.

This study, named RaDiCo-MPS, is not about testing new medicines or treatments. Instead, it's like a big detective story. Researchers are gathering lots of information about people in France who have MPS conditions. They are looking at their medical history, how their conditions have developed, and their general health over time. This helps create a detailed picture of what it's like to live with MPS.

The main aim is to get a much better understanding of these rare conditions. By collecting all this information, scientists hope to learn more about how MPS affects people, how it changes over time, and what common patterns emerge. This greater knowledge is crucial because it can help doctors diagnose MPS earlier, develop better ways to manage the symptoms, and eventually lead to new and improved treatments for people living with these conditions.

Key takeaways

  • This study helps doctors learn more about rare MPS conditions.
  • It's an 'observational' study, meaning no new treatments are given.
  • Information is collected from existing medical records and routine care.
  • Your contribution helps improve future care for MPS patients.
  • Participation is voluntary, and you can withdraw anytime.
  • Data from all ages and both sexes are included.

Who may be eligible?

Anyone of any age, male or female, can take part in this study. The most important thing is that you have a confirmed diagnosis of one of the specific MPS conditions that the researchers are looking at.

To be considered for the study, doctors need to have already found problems with specific enzymes in your body. They also need to have found unusual levels of certain sugar molecules (called GAG) in your urine, or have identified specific genetic changes (mutations) in your DNA that confirm you have MPS.

If you are under 18 or someone who needs help making decisions, a parent or guardian will need to give their permission for you to be included. If a patient is no longer alive, their parent or guardian can still give permission for their medical records to be included in the study.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. Do I have a confirmed diagnosis of an MPS condition?
  2. Have doctors identified enzyme problems related to my MPS?
  3. Do my medical records show unusual levels of GAG or specific genetic changes?
  4. If I am under 18, has my parent or guardian agreed to my participation?
Answer every question to see your result.

What does participation involve?

As this is an 'observational' study, it’s different from studies that test new medicines. You won't be given any new treatments or asked to change your current medical care. Instead, taking part mainly involves allowing the research team to collect information from your existing medical records. This might include details about your diagnosis, symptoms, and how your condition has progressed over time.

If you are still receiving care, the research team might also collect information from your routine clinic visits. You might have some extra assessments during these regular appointments, but you won't need to make special trips just for the study. There are no study medications to take, and no specific follow-up appointments outside of your usual care. The total duration of your participation could depend on how long your medical records are available or how long you continue to be seen in clinic.

Potential risks and benefits

A potential benefit of taking part is that the information gathered from your experience could help other people with MPS in the future by improving our understanding of these rare conditions. This could lead to better diagnoses and care. As you're not trying new treatments, there are very few direct risks. The main risk is linked to your privacy, as your medical information will be used for research, but strict steps are always taken to protect your details and keep them confidential. You are always free to change your mind and withdraw from the study at any time without it affecting your medical care.

Locations (23)

  • Centre Hospitalier Universitaire d'Angers
    Verified postcode
    Angers, France· Recruiting
  • Hôpital des Enfants - Groupe Hospitalier Pellegrin
    Verified postcode
    Bordeaux, France· Not yet recruiting
  • Hôpital Morvan
    Verified postcode
    Brest, France· Recruiting
  • Hôpital d'Estaing
    Verified postcode
    Clermont-Ferrand, France· Not yet recruiting
  • Hôpital Beaujon
    Verified postcode
    Clichy, France· Recruiting
  • Hôpital Raymond-Poincaré
    Verified postcode
    Garches, France· Not yet recruiting
  • Hôpital Jeanne de Flandre
    Verified postcode
    Lille, France· Recruiting
  • Hôpital de la Timone
    Verified postcode
    Marseille, France· Recruiting
  • Hôpital Gui de Chauliac
    Verified postcode
    Montpellier, France· Recruiting
  • Hôpital Brabois
    Verified postcode
    Nancy, France· Recruiting
  • Hôpital Armand Trousseau
    Verified postcode
    Paris, France· Recruiting
  • Hôpital de la Croix Saint-Simon
    Verified postcode
    Paris, France· Not yet recruiting

Common questions

What is an 'observational study'?

It means researchers are watching and collecting information about what's already happening, rather than testing a new treatment.

Will I get new medicine in this study?

No, this study doesn't involve giving any new medicines. It's about collecting information from your existing medical journey.

Do I need to visit the hospital more often?

You won't need extra hospital visits just for the study. Information will be collected from your normal medical appointments.

Who can join this study?

Anyone with a confirmed diagnosis of one of the listed MPS conditions can join, regardless of age or gender.

What happens with my personal information?

Your privacy is very important. All your medical information will be kept confidential and anonymised as much as possible for the research.

How to find out more

Bénédicte HERON

Always speak to your GP or specialist before deciding to take part in a study.

Interested in taking part?

Register your interest

Share your details and the research team for "MPS (RaDiCo Cohort) (RaDiCo-MPS)…" will contact you if you may be eligible. Always speak to your GP before agreeing to take part.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.